Treatment algorithms in treatment-resistant depression

Psychiatric Clinics of North America

Volumn 19, Issue 2, 1996, Pages 371-386

  Amsterdam, J D ^a   Hornig Rohan, M ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; LITHIUM CARBONATE; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ALGORITHM; DEPRESSION; DOSE RESPONSE; DRUG BLOOD LEVEL; HOST RESISTANCE; HUMAN; MEDICAL DECISION MAKING; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT PLANNING;

EID: 0030002489     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0193-953X(05)70293-8     Document Type: Article

References (72)

1. J. Amsterdam Pharmacotherapy of Depression: Applications for the Outpatient Practitioner 1990 Marcel Dekker New York
2. J. Amsterdam Refractory Depression 1991 Raven Press New York
3. J.D. Amsterdam Use of high dose tranylcypromine in resistant depression J. Amsterdam Refractory Depression 1991 Raven Press New York 123 130
4. J.D. Amsterdam G. Maislin Fluoxetine efficacy in treatment resistant depression Prog Neuropsychopharmacol Biol Psychiatry 18 1994 243 261
5. J.D. Amsterdam D. Brunswick J. Mendels High dose desipramine, plasma drug levels, and clinical response J Clin Psychiatry 40 1979 141 143
6. J.D. Amsterdam D.J. Brunswick J. Mendels The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels Am J Psychiatry 137 1980 653 662
7. J.D. Amsterdam D.J. Brunswick L. Potter Desipramine and 2-hydroxydesipramine plasma levels in endogenous depressed patients: Lack of correlation with therapeutic response Arch Gen Psychiatry 42 1985 361 364
8. M. Asberg Treatment of depression with tricyclic drugs—Pharmacokinetic and pharmacodynamic aspects Pharmakopsychiatr Neuropsychopharmacol 9 1976 18 26
9. C.M. Beasley Jr D.N. Masica J.H. Heiligenstein Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: Fluoxetine clinical data and preclinical findings J Clin Psychopharmacol 13 1993 312 320
10. C.M. Beasley Jr M.E. Sayler G.E. Cunningham Fluoxetine in tricyclic refractory major depressive disorder J Affect Disord 20 1990 193 200
11. D.W. Black S. Bell J. Hulbert The importance of axis II in patients with major depression: A controlled study J Affect Disord 14 1988 115 122
12. P. Benfield R.C. Heel S.P. Lewis Fluoxetine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness Drugs 32 1986 481 508
13. P. Blier C. de Montigny A.J. Azzaro Modification of serotonergic and noradrenergic neurotransmission by long-term administration of monoamine oxidase inhibitors Society Neuroscience Abstracts 10 1984 16
14. G. Chouinard B.D. Jones S.N. Young Potentiation of lithium by tryptophan in a patient with bipolar illness Am J Psychiatry 136 1979 719 720
15. J.O. Cole A.F. Schatzberg C. Sniffin Trazodone in treatment-resistant depression: An open study J Clin Psychopharmacol 1 suppl 1981 49 54
16. A. Coppen P.C. Whybrow R. Noguera The comparative antidepressant value of l -tryptophan and imipramine with and without attempted potentiation by liothyronine Arch Gen Psychiatry 26 1972 234 241
17. J. Davidson Adding a tricyclic antidepressant to a monoamine oxidase inhibitor J Clin Psychopharmacol 3 1982 216
18. J.M. Davis P.G. Janicak K. Bruninga The efficacy of MAO inhibitors in depression: A meta-analysis Psychiatr Ann 17 1987 825 831
19. C. de Montigny R. Elie G. Caille Rapid response to the addition of lithium in iprindol-resistant unipolar depression: A pilot study Am J Psychiatry 142 1985 220 223
20. C. de Montigny G. Cournover R. Morissette Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression Arch Gen Psychiatry 40 1983 1327 1334
21. C. de Montigny F. Grunberg A. Mayer Lithium induced rapid relief of depression in tricyclic antidepressant drug nonresponders Br J Psychiatry 138 1981 252 256
22. B.V. Earle Thyroid hormone and tricyclic antidepressants in resistant depression Am J Psychiatry 126 1970 143 145
23. M. Fava J.F. Rosenbaum P.J. McGrath Lithium and tricyclic augmentation of fluoxetine treatment for resistant depression: A double-blind, controlled study Am J Psychiatry 151 1994 1372 1374
24. J.P. Feighner J. Herbstein N. Damlouji Combined MAOI, TCA and direct stimulant therapy of treatment resistant depression J Clin Psychiatry 46 1985 206 209
25. J.P. Feighner I.J. King M.A. Schuckit Hormonal potentiation of imipramine and ECT in primary depression Am J Psychiatry 128 1972 50 58
26. A. Georgotas R.E. McCue E. Friedman The response of depressive symptoms to nortriptyline, phenelzine, and placebo Br J Psychiatry 151 1987 102 106
27. 3 to potentiate tricyclic antidepressant response J Affect Disord 13 1987 267 272
28. A.H. Glassman S.R. Platman Potentiation of monoamine oxidase inhibitor by tryptophan J Psychiatr Res 7 1969 83 88
29. A.H. Glassman J.M. Perel M. Shostak Clinical implications of imipramine plasma levels for depressive illness Arch Gen Psychiatry 34 1977 197 204
30. J.B. Greenhouse D.J. Kupfer E. Frank Analysis of time to stabilization in the treatment of depression: Biological and clinical correlates J Affect Disord 13 1987 259 266
31. B.H. Guze L.R. Baxter Jr Refractory depression treated with high doses of a monoamine oxidase inhibitor J Clin Psychiatry 48 1987 31 32
32. R.C. Hall E.R. Gardner E.R. Popkin Unrecognized physical illness prompting psychiatric admission: A prospective study Am J Psychiatry 138 1981 629 635
33. G.R. Heninger D.S. Charney D.E. Sternberg Lithium carbonate augmentation of antidepressant treatment Arch Gen Psychiatry 40 1983 1335 1342
34. J.M. Himmelhoch M.E. Thase A.C. Mallinger Tranylcypromine versus imipramine in anergic bipolar depression Am J Psychiatry 148 1991 910 916
35. R.T. Joffe W. Singer Thyroid hormone potentiation of antidepressants J.D. Amsterdam Refractory Depression 1991 Raven Press New York 185 190
36. M.B. Keller Undertreatment of major depression Psychopharmacol Bull 24 1988 75 80
37. M.B. Keller G.L. Klerman P.W. Lavori Treatment received by depressed patients JAMA 248 1982 1848 1855
38. M.L.B. Keller P.W. Lavori J. Rice The persistent risk of chronicity in recurrent episodes of nonbipolar depressive disorder: A prospective follow-up Am J Psychiatry 143 1986 24 28
39. M.R. Liebowitz F.M. Quitkin J.W. Stewart Phenelzine vs. imipramine in atypical depression: A preliminary report Arch Gen Psychiatry 41 1984 669 677
40. P.J. McGrath J.W. Stewart W. Harrison Treatment of tricyclic refractory depression with a monoamine oxidase inhibitor Psychopharmacol Bull 23 1987 169 172
41. J.C. Nelson R. Byck Rapid response to lithium in phenelzine nonresponders Br J Psychiatry 141 1982 85 86
42. A. Nierenberg K. White What next?: A review of pharmacologic strategies for treatment resistant depression Psychopharmacol Bull 26 1990 429 460
43. A.A. Nierenberg J.D. Amsterdam Resistant depression: Definition and treatment approaches J Clin Psychiatry 51 suppl 1990 39 47
44. W. Nolen J. Zohar S. Roose J.D. Amsterdam Refractory Depression: Current Strategies and Future Directions 1994 John Wiley & Sons Chichester
45. W.A. Nolen J.J. van de Putte W.A. Dijken MAO inhibitors in depression resistant to cyclic antidepressants: Two controlled cross-over studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine Acta Psychiatr Scand 78 1988 676 683
46. W.A. Nolen J.J. van de Putte W.A. Dijken Treatment strategy in depression: I. Non-tricyclic and selective reuptake inhibitors in resistant depression: A double-blind, partial cross-over study on the effects of oxaprotiline and fluvoxamine Acta Psychiatr Scand 78 1988 668 675
47. C. Nystrom T. Hallstrom Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients: A cross-over study Acta Psychiatr Scand 75 1987 377 382
48. C.M.B. Pare Potentiation of monoamine oxidase inhibitors by tryptophan Lancet ii 1963 527 528
49. A.C. Pandy M.M. Calarco L.J. Grunhaus Combined MAOI-TCA antidepressant treatment in refractory depression J.D. Amsterdam Refractory Depression 1991 Raven Press New York 115 121
50. H.G. Pope Jr S.L. McElroy R.A. Nixon Possible synergism between fluoxetine and lithium in refractory depression Am J Psychiatry 145 1988 10
51. A.J. Prange Jr I.C. Wilson A.M. Rabon Enhancement of imipramine antidepressant activity by thyroid hormone Am J Psychiatry 126 1969 39 51
52. L.H. Price Lithium augmentation in tricyclic-resistant depression I.L. Extein Treatment of Tricyclic-Resistant Depression 1989 American Psychiatric Press Washington, DC 49 79
53. L.H. Price D.S. Charney G.R. Heninger Efficacy of lithium-tranylcypromine treatment in refractory depression Am J Psychiatry 142 1985 619 623
54. F. Quitkin A. Rifkin D.F. Klein Monoamine oxidase inhibitors: A review of antidepressant effectiveness Arch Gen Psychiatry 35 1979 749 760
55. F.W. Reimherr D.R. Wood B. Byerly Characteristics of responders to fluoxetine Psychopharmacol Bull 20 1984 70 73
56. S.P. Roose Selective serotonin reuptake inhibitors in refractory depression W. Nolen J. Zohar S. Roose J.D. Amsterdam Refractory Depression: Current Strategies and Future Directions 1994 John Wiley & Sons Chichester 37 46
57. S.P. Roose A.H. Glassman B.T. Walsh Tricyclic nonresponders: Phenomenology and treatment Am J Psychiatry 143 1986 345 348
58. J.S. Rosenthal M.J. Kasawan C. Hemlock Fluoxetine enhancement of heterocyclic antidepressants J.D. Amsterdam Refractory Depression 1991 Raven Press New York 105 108
59. Rosenzweig MH, Amsterdam JD: Clomipramine augmentation in treatment resistant depression [abstract]. Presented at the Second International Conference on Refractory Depression, Amsterdam, The Netherlands, June 25, 1992
60. J.K. Rybakowski Lithium potentiation of antidepressants J.D. Amsterdam Pharmacotherapy of Depression 1990 Marcel Dekker New York 225 240
61. E. Schweizer K. Rickels J.D. Amsterdam What constitutes an adequate antidepressant trial of fluoxetine? J Clin Psychiatry 51 1990 8 11
62. C. Shawcross P. Tyrer The place of monoamine oxidase inhibitors in the treatment of resistant depression J. Zohar H. Belmaker Treatment Resistant Depression 1987 PMA Press New York 257 268
63. L. Solyom R.E. Gibson Fluoxetine in refractory depression Biol Psychiatry 27 1990 461 463
64. S.D. Targum R.D. Greenberg R.L. Harmon The TRH test and thyroid hormone in refractory depression [letter] Am J Psychiatry 141 1984 463
65. M.E. Thase D.J. Kupfer E. Frank Treatment of imipramine-resistant recurrent depression: II. An open, clinical trial of lithium augmentation J Clin Psychiatry 50 1989 413 417
66. P. Tyrer Towards rational treatment with monoamine oxidase inhibitors Br J Psychiatry 128 1976 354 360
67. S.G. Wagner D.F. Klein Drug therapy strategies for treatment resistant depression Psychopharmacol Bull 24 1988 69 74
68. J.B. Weilburg J.F. Rosenbaum J. Biederman Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: A preliminary report J Clin Psychiatry 40 1989 447 449
69. D. Wheatley Potentiation of amitriptyline by thyroid hormone Arch Gen Psychiatry 26 1972 229 223
70. K. White G. Simpson Combined MAOI-tricyclic antidepressant treatment: A reassessment J Clin Psychopharmacol 1 1981 264 282
71. I.C. Wilson A.J. Prange Jr T.K. McClane Thyroid hormone enhancement of imipramine in nonretarded depression N Engl J Med 282 1970 1063 1067
72. J. Zohar R.H. Belma Ker Treating Resistant Depression 1987 PMA Publishing New York 1 427